Anatomic Stage II Breast Cancer AJCC v8 trials recruiting in North Carolina

All Anatomic Stage II Breast Cancer AJCC v8 trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Cary, Chapel Hill, Clinton, Garner
• Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
  NCT07474090 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · North Carolina: Winston-Salem
• ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
  NCT06876714 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Cary, Chapel Hill, Charlotte, Clemmons
• Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
  NCT05929768 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Asheboro, Asheville, Burlington, Chapel Hill
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
  NCT07391774 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Cary, Clinton, Durham, Goldsboro